These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1749077)

  • 1. [Virulence factors of Pseudomonas aeruginosa in mice].
    Goto S; Miyazaki S; Ohno A
    Nihon Rinsho; 1991 Oct; 49(10):2227-32. PubMed ID: 1749077
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of alkaline protease and elastase in the adherence of Pseudomonas aeruginosa to WEHI cells.
    Trancassini M; Magni A; Ghezzi MC; Nazzari C; Brenciaglia MI; Filadoro F
    Microbiologica; 1989 Jul; 12(3):257-61. PubMed ID: 2506409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of subinhibitory concentrations of norfloxacin, erythromycin and roxithromycin on Pseudomonas aeruginosa virulence factors].
    Hostacká A
    Epidemiol Mikrobiol Imunol; 1995 Sep; 44(3):115-7. PubMed ID: 7489133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent progress of Pseudomonas aeruginosa infections; pathological mechanisms of new toxic metabolites].
    Homma JY
    Nihon Rinsho; 1991 Oct; 49(10):2201-6. PubMed ID: 1749074
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudomonas aeruginosa exoproteases inhibit human neutrophil chemiluminescence.
    Kharazmi A; Høiby N; Döring G; Valerius NH
    Infect Immun; 1984 Jun; 44(3):587-91. PubMed ID: 6327528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA
    Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotyping and virulence factors of Pseudomonas aeruginosa clinical isolates.
    Hostacká A; Majtán V
    Acta Microbiol Immunol Hung; 1997; 44(2):141-6. PubMed ID: 9330662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of superoxide dismutase gene inactivation on virulence of Pseudomonas aeruginosa PAO1 toward the silkworm, Bombyx mori.
    Iiyama K; Chieda Y; Lee JM; Kusakabe T; Yasunaga-Aoki C; Shimizu S
    Appl Environ Microbiol; 2007 Mar; 73(5):1569-75. PubMed ID: 17220257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postantibiotic effect and virulence factors depression induced by ciprofloxacin and by aminoglycosides in a clinical isolate of Pseudomonas aeruginosa.
    Hostacka A
    Zentralbl Bakteriol; 1996 Mar; 283(3):322-7. PubMed ID: 8861870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Peptidase activity and toxicity of strains of Pseudomonas aeruginosa].
    Pinna GG; Spano A; Carru C; Pes GM; Delogu G; Miscali AR; Zanetti S; Sisini A
    Boll Soc Ital Biol Sper; 1991 Mar; 67(3):287-94. PubMed ID: 1930904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Presence of extracellular proteases in Pseudomonas aeruginosa].
    Pájaro MC; Albesa I
    Rev Argent Microbiol; 1989; 21(3-4):149-52. PubMed ID: 2518595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa proteases: purification procedures for an enzymatic standard.
    Cristallo A; Passi A; Bruseghini L; Cereda PM
    New Microbiol; 1996 Jul; 19(3):221-6. PubMed ID: 8841037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenicity factors in Pseudomonas aeruginosa (proceedings)].
    Scharmann W
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):20-5. PubMed ID: 824891
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of exotoxin, protease and elastase of Pseudomonas aeruginosa strains isolated from patients' and environmental specimens.
    Sanai Y; Takeshi K; Homma JY; Kamata H
    Jpn J Exp Med; 1978 Dec; 48(6):553-6. PubMed ID: 108441
    [No Abstract]   [Full Text] [Related]  

  • 18. KatA, the major catalase, is critical for osmoprotection and virulence in Pseudomonas aeruginosa PA14.
    Lee JS; Heo YJ; Lee JK; Cho YH
    Infect Immun; 2005 Jul; 73(7):4399-403. PubMed ID: 15972537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea.
    Gupta SK; Masinick SA; Hobden JA; Berk RS; Hazlett LD
    Exp Eye Res; 1996 Jun; 62(6):641-50. PubMed ID: 8983946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of elastase from Pseudomonas aeruginosa with polymorphonuclear leukocytes and serum.
    Pajdak E; Pituch-Noworolska A; Stankiewicz D
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):499-505. PubMed ID: 3936453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.